Recent Quarter Total Invested
$1.03 B
Recent Quarter Institutional Ownership Percentage
86.01%
Total Invested of Last Quarter
$1.20 B
Ownership Percentage of Last Quarter
90.77%
Day One Biopharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 7.87 M | $108.47 M | 0.79% | 9.08% |
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 08/09/2024 | 6.43 M | $88.61 M | 0.00% | 7.42% |
VANGUARD GROUP INC | 08/13/2024 | 4.62 M | $63.71 M | -3.17% | 5.33% |
BLACKROCK INC. | 08/13/2024 | 4.53 M | $62.47 M | -9.90% | 5.23% |
FRANKLIN RESOURCES INC | 08/14/2024 | 3.78 M | $52.12 M | -0.64% | 4.36% |
BRAIDWELL LP | 08/14/2024 | 3.04 M | $41.83 M | 39.67% | 3.50% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2024 | 2.92 M | $40.28 M | 65.59% | 3.37% |
PICTET ASSET MANAGEMENT HOLDING SA | 08/13/2024 | 2.85 M | $39.29 M | 20.06% | 3.29% |
STATE STREET CORP | 08/14/2024 | 2.83 M | $38.95 M | -2.35% | 3.26% |
FMR LLC | 08/13/2024 | 2.66 M | $36.67 M | -39.57% | 3.07% |
ESTUARY CAPITAL MANAGEMENT LP | 08/14/2024 | 2.64 M | $36.31 M | 63.57% | 3.04% |
VIKING GLOBAL INVESTORS LP | 08/14/2024 | 2.56 M | $35.26 M | 0.00% | 2.95% |
PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 2.35 M | $32.40 M | 2.22% | 2.71% |
GOLDMAN SACHS GROUP INC | 08/13/2024 | 1.90 M | $26.22 M | -10.97% | 2.20% |
JANUS HENDERSON GROUP PLC | 08/14/2024 | 1.84 M | $25.36 M | -9.50% | 2.12% |
TIMESSQUARE CAPITAL MANAGEMENT, LLC | 08/08/2024 | 1.69 M | $23.27 M | 3.27% | 1.95% |
GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.30 M | $17.87 M | -5.86% | 1.50% |
VESTAL POINT CAPITAL, LP | 08/14/2024 | 1.25 M | $17.23 M | 100.00% | 1.44% |
MAVERICK CAPITAL LTD | 08/14/2024 | 1.21 M | $16.69 M | -3.62% | 1.40% |
BOXER CAPITAL, LLC | 08/14/2024 | 1.19 M | $16.40 M | 0.00% | 1.37% |
POLAR CAPITAL HOLDINGS PLC | 08/14/2024 | 935,000 | $12.88 M | -21.10% | 1.08% |
PARKMAN HEALTHCARE PARTNERS LLC | 08/14/2024 | 908,822 | $12.52 M | 31.37% | 1.05% |
DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 888,117 | $12.24 M | -9.52% | 1.02% |
WOODLINE PARTNERS LP | 08/14/2024 | 707,531 | $9.75 M | 159.61% | 0.82% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 08/15/2024 | 706,446 | $9.73 M | -1.75% | 0.82% |
DAFNA CAPITAL MANAGEMENT LLC | 08/14/2024 | 666,463 | $9.18 M | 0.00% | 0.77% |
HUDSON BAY CAPITAL MANAGEMENT LP | 08/14/2024 | 555,108 | $7.65 M | 404.64% | 0.64% |
ALLY BRIDGE GROUP (NY) LLC | 08/14/2024 | 536,095 | $7.39 M | 100.00% | 0.62% |
NORTHERN TRUST CORP | 08/14/2024 | 533,039 | $7.35 M | -4.50% | 0.62% |
POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 470,247 | $6.48 M | 100.00% | 0.54% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 442,748 | $6.10 M | -3.26% | 0.51% |
PFM HEALTH SCIENCES, LP | 08/14/2024 | 396,644 | $5.47 M | 11.65% | 0.46% |
CITADEL ADVISORS LLC | 08/14/2024 | 369,608 | $5.09 M | 681.99% | 0.43% |
SPHERA FUNDS MANAGEMENT LTD. | 08/14/2024 | 347,627 | $4.79 M | -29.43% | 0.40% |
TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 299,206 | $4.12 M | 1,365.83% | 0.35% |
WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 298,038 | $4.11 M | 9.53% | 0.34% |
CANDRIAM S.C.A. | 08/05/2024 | 290,014 | $4.00 M | 0.00% | 0.33% |
SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 244,957 | $3.38 M | 3.03% | 0.28% |
D. E. SHAW & CO., INC. | 08/14/2024 | 224,340 | $3.09 M | 0.05% | 0.26% |
BANK OF NEW YORK MELLON CORP | 07/25/2024 | 208,396 | $2.87 M | -3.24% | 0.24% |
DEUTSCHE BANK AG\ | 08/14/2024 | 201,867 | $2.78 M | 13.30% | 0.23% |
MONASHEE INVESTMENT MANAGEMENT LLC | 08/12/2024 | 200,000 | $2.76 M | 100.00% | 0.23% |
SAMSARA BIOCAPITAL, LLC | 08/14/2024 | 196,425 | $2.71 M | 0.00% | 0.23% |
NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 190,906 | $2.63 M | 8.61% | 0.22% |
SQUAREPOINT OPS LLC | 08/14/2024 | 186,484 | $2.57 M | 100.00% | 0.22% |
JANE STREET GROUP, LLC | 08/15/2024 | 179,784 | $2.48 M | 216.67% | 0.21% |
BANK OF AMERICA CORP /DE/ | 08/14/2024 | 177,666 | $2.45 M | 39.25% | 0.21% |
KENNEDY CAPITAL MANAGEMENT LLC | 08/14/2024 | 173,738 | $2.39 M | 100.00% | 0.20% |
LAURION CAPITAL MANAGEMENT LP | 08/14/2024 | 171,887 | $2.37 M | 4.18% | 0.20% |
NORGES BANK | 08/14/2024 | 169,000 | $2.33 M | 100.00% | 0.20% |
Day One Biopharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of DAWN shares?
During the previous two years, 183 institutional investors and hedge funds held shares of Day One Biopharmaceuticals, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 7.87 M
Atlas Venture Life Science Advisors, LLC: 6.43 M
VANGUARD GROUP INC: 4.62 M
BlackRock Inc.: 4.53 M
FRANKLIN RESOURCES INC: 3.78 M
BRAIDWELL LP: 3.04 M
-
What percentage of Day One Biopharmaceuticals, Inc. stock is owned by institutional investors?
86.01% of Day One Biopharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at DAWN ?
Institutional investors have bought a total of 74.85 M shares in the last 24 months. This purchase volume represents approximately $1.05 B in transactions.